Drug profile · INN
incobotulinumtoxina
XEOMIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
incobotulinumtoxina (XEOMIN) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN incobotulinumtoxina
Brand XEOMIN
Route INJECTION
Formulation INJECTABLE
Originator Lacuna Pharma Pty Ltd
Frequently asked questions
What is incobotulinumtoxina?
incobotulinumtoxina (XEOMIN) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for incobotulinumtoxina?
XEOMIN is a marketed brand name for incobotulinumtoxina. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of incobotulinumtoxina?
incobotulinumtoxina has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.